Rats With High Ghrelin Levels Become Obese But Paradoxically Have Better Blood Sugar Control | Research

The takeaway

MENX rats with genetically elevated ghrelin levels develop obesity and high blood lipids but show improved insulin sensitivity, revealing a paradoxical metabolic role for this hunger peptide.

Improved insulin sensitivity despite obesity
MENX rats with chronically elevated ghrelin developed obesity but maintained better blood sugar control than expected, suggesting ghrelin has insulin-sensitizing effects independent of its appetite-stimulating role

What the researchers found

MENX rats with a p27 mutation developed pancreatic islet hyperplasia with elevated numbers of ghrelin-producing ε-cells, resulting in high plasma levels of both acylated and unacylated ghrelin. These rats showed increased food intake, enhanced body fat mass, and elevated triglycerides and cholesterol — effects confirmed by GHS-R1a antagonist treatment.

Paradoxically, despite obesity, MENX rats showed improved insulin sensitivity and decreased glucose-stimulated insulin secretion. At 7.5 months, hypothalamic GHS-R1a, NPY, and AgRP mRNA levels were decreased, suggesting prolonged high ghrelin may lead to reduced ghrelin signaling effectiveness (desensitization).

Why it matters

The finding that high ghrelin can drive obesity while simultaneously improving insulin sensitivity challenges the simplistic view of ghrelin as just a hunger hormone. Understanding how ghrelin separately regulates appetite and blood sugar could reveal new therapeutic targets — potentially allowing doctors to harness ghrelin's insulin-sensitizing effects without promoting weight gain.

How the study worked

MENX rats carrying a natural p27 mutation were characterized for metabolic phenotype including plasma ghrelin levels (acylated and unacylated), food intake, body fat composition, lipid profiles, and glucose metabolism. Hypothalamic gene expression (GHS-R1a, NPY, AgRP) was measured by mRNA analysis. A GHS-R1a antagonist was used to pharmacologically confirm ghrelin's role in increased food intake. Pancreatic tissue was analyzed for ghrelin-producing cell populations.

What this study cannot tell us

This is an animal study using a specific genetic rat model (MENX), which may not fully represent human physiology. The p27 mutation causes multiple endocrine neoplasia, so effects may not be solely attributable to ghrelin elevation. The mechanisms underlying improved insulin sensitivity despite obesity were not fully elucidated. Sample sizes were not detailed in the abstract.

How to read the evidence

This is a preclinical study using a genetically defined rat model published in Diabetes, a leading journal. The model provides a unique opportunity to study chronic endogenous ghrelin elevation, but the specific genetic context (MENX syndrome) limits direct extrapolation to human obesity.

When this study was published

Published in 2016, this study contributed to the evolving understanding of ghrelin's complex metabolic roles. Subsequent research has continued to explore the dissociation between ghrelin's appetite and metabolic effects.

The bigger picture

Ghrelin's dual role in appetite and metabolism is one of the most fascinating areas in peptide endocrinology. This study provides a natural genetic model showing that ghrelin's metabolic effects can be dissociated — obesity doesn't always mean insulin resistance. This insight is relevant to the development of ghrelin-based therapies and to understanding why some obese individuals maintain good blood sugar control while others develop diabetes.

Questions still open

Could unacylated ghrelin (des-acyl ghrelin) be responsible for the insulin-sensitizing effects separate from acylated ghrelin's appetite stimulation?
Is the ghrelin receptor desensitization observed at 7.5 months a protective mechanism against continued overeating?
Could drugs targeting specific ghrelin pathways improve insulin sensitivity in obese humans without increasing appetite?

Common questions

What is ghrelin and why is it called the hunger hormone?

Ghrelin is a peptide hormone primarily produced in the stomach that signals to the brain to stimulate appetite and food intake. Its levels rise before meals and fall after eating. It also affects growth hormone release, fat storage, and — as this study shows — insulin sensitivity. It's called the 'hunger hormone' because it's the primary biological signal that makes you feel hungry.

How can rats be obese but have better blood sugar control?

This paradox challenges the common assumption that obesity always worsens blood sugar control. In these rats, chronically elevated ghrelin appears to improve how their cells respond to insulin (insulin sensitivity), even as it simultaneously drives weight gain through increased appetite. This suggests ghrelin activates separate pathways for appetite and metabolism, and that these can be dissociated — opening the possibility of targeting one without affecting the other.

Read the original research

Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity.

Diabetes, 65(2), 406-20

View on PubMed ↗Publisher’s paper ↗

Citation

Wiedemann, Tobias; Bielohuby, Maximilian; Müller, Timo D; Bidlingmaier, Martin; Pellegata, Natalia S. (2016). Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity.. Diabetes, 65(2), 406-20. https://doi.org/10.2337/db15-0374